La combinaison TMB-365/TMB-380 démontre une suspension virale sans nécessité d’épreuve de sensibilité TaiMed Biologics va revoir la gestion des traitement contre le VIH et recherche des collaborations stratégiques avec des partenaires pharmaceutiques mondiaux pour commercialiser sa…
Month: March 2025
TMB-365/TMB-380 Combination Demonstrates Viral Suspension Without the Need for Susceptibility Screening TaiMed Biologics will reshape HIV treatment management and seeks strategic collaborations with global pharmaceutical partners for the commercialization of its long-acting HIV…
– TaiMed Biologics anuncia en la CROI 2025 los resultados de los últimos datos de fase 2a sobre la terapia de mantenimiento de acción prolongada contra el VIH La combinación TMB-365/TMB-380 demuestra la suspensión viral sin necesidad de pruebas de susceptibilidad TaiMed Biologics…
INDIANAPOLIS, March 17, 2025 /PRNewswire/ — Calumet, Inc. (NASDAQ: CLMT) (the “Company,” “Calumet,” “we”) today announced that Julio Quintana and Karen Narwold have been selected as nominees for election to the Board of Directors of Calumet (the “Board”) at the Company’s 2025 Annual…
NEW YORK, March 17, 2025 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Neumora Therapeutics, Inc. (NASDAQ: NMRA) pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Offering…
LOS ANGELES, March 17, 2025 /PRNewswire/ — The DJS Law Group announces that it is investigating claims on behalf of investors of Lineage, Inc. (“Lineage” or “the Company”) (NASDAQ: LINE) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether…
LOS ANGELES, March 17, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Lineage, Inc. (“Lineage” or “the Company”) (NASDAQ: LINE) for violations of the securities laws. The…
LOS ANGELES, March 17, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ibotta, Inc. (“Ibotta” or “the Company”) (NYSE: IBTA) for violations of the securities laws. The…
LOS ANGELES, March 17, 2025 /PRNewswire/ — The DJS Law Group reminds investors of a class action lawsuit against encore Energy Corp. (“enCore” or “the Company”) (NASDAQ: EU) for violations of the federal securities laws. Shareholders who purchased the Company’s securities between March…
The oncology therapy landscape is rapidly evolving, with immune checkpoint inhibitors reshaping cancer treatment by leveraging the body’s own immune system to combat tumors. As the immune checkpoint inhibitors market grows, pharmaceutical companies must make informed decisions about…